dm+d

414005006

Articles

Safety in Lactation: Vaccines and antisera

21 September 2020Although vaccines and toxoids (diphtheria and tetanus) are considered to be compatible with breastfeeding, their use should be limited to those situations where there is…
Search Articles

Refrigerated Storage

Boostrix-IPVGlaxoSmithKline UK

GlaxoSmithKline UK
Boostrix-IPV
Suspension for injection in pre-filled syringe

In the event of an inadvertent temperature excursion the following data may be used:
The vaccine is stable for 8 hours at 21°C. Discard the vaccine if it is not used during this period.
Contact GlaxoSmithKline UK in cases where additional stability data is required.
Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Public Health England has guidance on responding to errors in vaccine storage, handling and administration.

Reduce to 8 hours if exposed to temperatures described above
No, if exposed to temperatures described above
21 October 2021
London MI Service

RepevaxSanofi Pasteur

Sanofi Pasteur
Repevax
Injection

Contact Sanofi Pasteur in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Public Health England has guidance on responding to errors in vaccine storage, handling and administration.

21 October 2020
London MI Service

Lactation Safety Information

Yes
In adults, used only to boost immunity in pregnant women – use during breastfeeding therefore unlikely. Available as combination inactivated vaccine - low dose diphtheria/tetanus/acellular pertussis/inactivated polio vaccine (dTaP/IPV)
16 September 2020